RxDoctor Payments Data

Howard Rosner, MD

Pain Medicine · West Hollywood, CANPI 1013915669

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $68,020 of the $79,023 with a category attached, or 86.1%. Avanos Medical accounts for 91.1% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2022 at $27,587 and has fallen 95.7% since, to $1,177 in 2025. Among pain medicine clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$79,023in general payments, 2019–2025

Across 128 payments — averaging $617.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Avanos Medical$72K
  • Boston Scientific$6K
  • Nevro Corp.$200
  • Vertos Medical, Inc.$151
  • Nalu Medical, Inc.$143
  • SPR Therapeutics, Inc$119
  • plus $129 from 4 others

What the payments were for

  • Speaking & faculty fees$68,02086%
  • Travel & lodging$5,6307%
  • Food & beverage$5,3277%
  • Education$450%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$79,023 in reported general payments places this provider in the 95th percentile of 840 pain medicine providers in California.

See all pain medicine providers in California

Medicare billing

Part B allowed, 2024
$114,763
Medicare patients
225
Services billed
1,061

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
NucyntaTapentadol Hcl14$14,973
ZubsolvBuprenorphine Hcl/Naloxone Hcl13$11,330
Buprenorphine24$6,447
Celecoxib20$3,404
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen55$1,714
Duloxetine Hcl14$711
Tramadol Hcl62$642
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen21$607
Gabapentin47$507
Tizanidine Hcl32$476
Pregabalin25$323
Meloxicam34$248
Etodolac14$246
Methadone Hcl22$220
Buprenorphine Hcl11$205

Paid to pharmacies, not to this prescriber.

Other pain medicine in West Hollywood

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →